Venus Remedies Limited has informed the Exchange regarding 'Declarartion of Dividend'.

Corporate Actions View source PDF Explain this filing

VENUSREM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.1%Reaction day

₹1160.00

prior close

₹1219.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.0%+5.1% vs market

Pharmaceuticals peers, median of 164sector+0.1%+5.0% vs sector

On the reaction day the stock moved 5.1 pts more than Nifty Microcap 250 and 5.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.1-0.0+5.1+0.1+5.0

Next day

+10.3-0.7+11.0-0.6+10.9

+15.9-1.8+17.6-1.3+17.2

+21.7-0.7+22.4-1.4+23.1

+27.7-0.5+28.2-1.6+29.3

+34.1+0.4+33.7-0.6+34.7

+41.9-1.6+43.5-2.3+44.2

15d

+48.5+4.6+43.9+0.0+48.5

+66.3+4.6+61.7+3.0+63.3

+35.6+6.1+29.4+4.3+31.3

+37.9+10.8+27.1+8.6+29.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Venus Remedies Limited has declared a final dividend of Rs. 10 per equity share (100% on face value of Rs. 10) for FY 2025-26, subject to shareholder approval at the 37th AGM on August 20, 2026. The record date to determine eligible shareholders is August 7, 2026. The company reported strong financial performance with standalone revenue from operations of Rs. 768.73 crore (up 19% from Rs. 644.47 crore) and net profit of Rs. 99.31 crore (up 89% from Rs. 52.55 crore). Consolidated net profit stood at Rs. 102.78 crore, nearly doubling from Rs. 45.31 crore in the previous year. EPS for standalone was Rs. 74.29 compared to Rs. 39.32 in FY 2024-25.

Likely market impact

The company has delivered exceptional profit growth of nearly 90% year-on-year, and the dividend declaration signals confidence in financial health. This positive earnings beat and shareholder-friendly payout should be viewed favorably by investors, potentially supporting the stock price ahead of the record date.